Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London
· Delayed Price · Currency is GBP · Price in USD 773.76
+16.76 (2.21%)
Mar 9, 2026, 4:55 PM GMT
Regeneron Pharmaceuticals Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 58,234 | 58,841 | 61,217 | 73,329 | 63,953 | 48,764 | Upgrade
|
| Market Cap Growth | -1.04% | -3.88% | -16.52% | 14.66% | 31.15% | 30.57% | Upgrade
|
| Enterprise Value | 46,365 | 46,935 | 48,770 | 63,131 | 55,414 | 42,324 | Upgrade
|
| Last Close Price | 567.72 | 574.41 | 559.90 | 684.11 | 587.39 | 467.25 | Upgrade
|
| PE Ratio | 17.40 | 17.58 | 17.37 | 23.63 | 17.76 | 8.18 | Upgrade
|
| PS Ratio | 5.46 | 5.52 | 5.40 | 7.12 | 6.33 | 4.11 | Upgrade
|
| PB Ratio | 2.51 | 2.53 | 2.61 | 3.60 | 3.40 | 3.52 | Upgrade
|
| P/TBV Ratio | 2.61 | 2.64 | 2.72 | 3.75 | 3.54 | 3.52 | Upgrade
|
| P/FCF Ratio | 19.21 | 19.41 | 20.91 | 24.10 | 17.42 | 10.11 | Upgrade
|
| P/OCF Ratio | 15.74 | 15.91 | 17.34 | 20.33 | 15.37 | 9.32 | Upgrade
|
| EV/Sales Ratio | 4.33 | 4.40 | 4.30 | 6.13 | 5.49 | 3.57 | Upgrade
|
| EV/EBITDA Ratio | 14.50 | 14.88 | 13.19 | 17.28 | 12.51 | 6.18 | Upgrade
|
| EV/EBIT Ratio | 16.77 | 17.06 | 14.73 | 19.00 | 13.37 | 6.37 | Upgrade
|
| EV/FCF Ratio | 15.29 | 15.48 | 16.66 | 20.75 | 15.09 | 8.78 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.10 | 0.10 | 0.11 | 0.12 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 0.69 | 0.69 | 0.63 | 0.60 | 0.52 | 0.29 | Upgrade
|
| Debt / FCF Ratio | 0.73 | 0.73 | 0.80 | 0.72 | 0.63 | 0.41 | Upgrade
|
| Net Debt / Equity Ratio | -0.51 | -0.51 | -0.51 | -0.52 | -0.51 | -0.52 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.74 | -3.74 | -3.23 | -2.89 | -2.17 | -1.06 | Upgrade
|
| Net Debt / FCF Ratio | -3.89 | -3.89 | -4.09 | -3.47 | -2.61 | -1.51 | Upgrade
|
| Asset Turnover | 0.37 | 0.37 | 0.40 | 0.42 | 0.45 | 0.76 | Upgrade
|
| Inventory Turnover | 2.53 | 2.53 | 2.51 | 2.51 | 2.37 | 2.74 | Upgrade
|
| Quick Ratio | 3.28 | 3.28 | 3.86 | 4.82 | 4.16 | 2.98 | Upgrade
|
| Current Ratio | 4.13 | 4.13 | 4.73 | 5.69 | 5.06 | 3.56 | Upgrade
|
| Return on Equity (ROE) | 14.87% | 14.87% | 15.95% | 16.26% | 20.94% | 54.21% | Upgrade
|
| Return on Assets (ROA) | 5.91% | 5.91% | 7.31% | 8.49% | 11.42% | 26.39% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.54% | 13.04% | 18.58% | 22.38% | 26.65% | 60.13% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.20% | 10.20% | 12.30% | 14.30% | 19.20% | 41.80% | Upgrade
|
| Earnings Yield | 5.75% | 5.69% | 5.76% | 4.23% | 5.63% | 12.23% | Upgrade
|
| FCF Yield | 5.21% | 5.15% | 4.78% | 4.15% | 5.74% | 9.89% | Upgrade
|
| Dividend Yield | 0.35% | 0.46% | - | - | - | - | Upgrade
|
| Payout Ratio | 8.22% | 8.22% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | 5.65% | 5.65% | -1.23% | -0.18% | -1.16% | 2.52% | Upgrade
|
| Total Shareholder Return | 6.00% | 6.10% | -1.23% | -0.18% | -1.16% | 2.52% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.